市場調查報告書
商品編碼
1517285
兩片空心硬膠囊的全球市場:按原料、尺寸、最終用戶和地區進行預測(~2032 年)Global Two-Piece Empty Hard Capsule Market Research Report Information by Raw Material (Gelatin Hydroxypropyl Methylcellulose, Starch and Pullulan), By size, By End Users And by Region - Forecast Till 2032 |
兩片空心硬膠囊的市場規模預計到 2023 年為 11.3 億美元,到 2024 年為 12.3 億美元,預測期內複合年增長率為 7.08%,預計到 2032 年將達到 22.3 億美元。
兩片裝空心硬膠囊市場正在迅速擴大,這主要是由於非傳染性疾病(NCD)盛行率的上升。世界衛生組織(WHO)估計,到2023年,非傳染性疾病每年將導致4,100萬人死亡,佔全球死亡人數的74%。全球肥胖、糖尿病和心血管疾病等疾病的盛行率不斷上升,以及藥品和營養補充劑使用的增加,促使對空心硬膠囊的需求增加。
膠囊易於吞嚥,可以掩蓋藥物的味道,這也有利於患者的依從性,特別是在長期治療計劃中。這與以患者為中心的藥物開發方法的更大行業趨勢非常吻合。
區域視角
北美地區在 2022 年佔據最大佔有率,為 36.60%,預計在預測期內將以 5.70% 的複合年增長率增長,並在 2032 年達到超過 7.1 億美元的規模。同時,亞太地區預計同期複合年增長率最高,達 8.89%。
北美兩片空心硬膠囊市場預計將呈現穩定成長,前景看好。由於對醫療保健基礎設施的投資和公眾對現代醫學意識的提高,預計市場將進一步擴大。
本報告調查了全球兩片空心硬膠囊市場,提供了市場定義和概述,影響市場成長和市場機會的因素分析,市場規模的趨勢和預測,並按各個細分市場、地區和主要國家進行了細分。
Global Two-Piece Empty Hard Capsule Market Research Report Information by Raw Material (Gelatin Hydroxypropyl Methylcellulose (HPMC), Starch and Pullulan), By size (Size "00" capsules, Size "0" capsules, Size "1" capsules, Size "2" capsules, others), By End Users (Pharmaceutical Companies, Health & Nutrition, Others) And by Region (North America, Europe, Asia-Pacific, And Rest of The World) - Forecast Till 2032
The size of the two-piece empty hard capsule market was estimated at USD 1.13 billion in 2023 and is expected to increase at a compound yearly growth rate (CAGR) of 7.08% from USD 1.20 billion in 2024 to USD 2.23 billion by 2032.
The market for two-piece empty hard capsules is expanding rapidly, driven mostly by the rising incidence of non-communicable diseases (NCDs). The World Health Organization (WHO) estimates that noncommunicable diseases (NCDs) would kill 41 million people year in 2023, making up 74% of all deaths globally. The demand for empty hard capsules has increased as a result of the increased use of pharmaceutical and nutraceutical therapies due to the rising prevalence of disorders including obesity, diabetes, and cardiovascular diseases around the world. These capsules are effective drug delivery systems that make it easier to provide different formulations to treat the complicated issues related to non-communicable diseases. Pharmaceutical companies are using two-piece empty hard capsules to encapsulate a wide range of medicinal substances, taking advantage of their adaptability as healthcare systems worldwide attempt to control and cure these common chronic illnesses.
Because the capsules are easy to swallow and hide the taste of pharmaceuticals, they also have a benefit in terms of patient compliance, particularly in long-term treatment regimes. This fits well with the larger industry trend of drug development methodologies that are patient centric.
Insights on Market Segments
Based on raw material, the global Two-Piece Empty Hard capsule segmentation comprises pullulan, gelatin, hydroxypropyl methylcellulose (HPMC), and starch.
Size-based market segmentation for two-piece empty hard capsules comprises of capsules with a "00" size, "0" size, "1" size, "2" size, and other sizes.
The end-user segmentation of the two-piece empty hard capsule market includes pharmaceutical businesses, health and nutrition, and other categories.
RegionalPerspectives
With the biggest market share of 36.60% in 2022, the North American two-piece empty hard capsule market is expected to grow at a 5.70% CAGR to reach over USD 0.71 billion by 2032. Nonetheless, throughout the course of the projection period, Asia-Pacific is expected to develop at the highest CAGR of 8.89%.
The two-piece empty hard capsule market in North America has a good future ahead of it, with steady growth predicted. Further market expansion is anticipated because of investments in healthcare infrastructure and rising public awareness of modern medical treatments.
Due to rising healthcare costs, the prevalence of chronic diseases, and technological improvements, the Europe Two-Piece Empty Hard Capsule Market had the second-largest market share.
The market for two-piece empty hard capsules in the Asia-Pacific region is anticipated to develop at the quickest rate between 2024 and 2032 due to the region's high patient population, rise in chronic illnesses, and advantageous regulatory framework. The expansion of major companies in the Two-Piece Empty Hard Capsule Market into this area is also propelling the growth of the regional market.
Principal Players
Important Businesses CapsCanada (Canada), Roxlor (US), Goerlich Pharma GmbH (Europe), Lonza (Switzerland), Qualicaps (US), Suheung (South Korea), ACG (India), Hunan Er-Kang Pharmaceutical Co. Ltd (China), Shanxi Guangsheng Medicinal Capsule Co., Ltd (China), and Bright Pharma Caps (US) are some of the companies that sell two-piece empty hard capsules on the market.